Evidence map›Paper›PMID 38860527›Full record

ReviewActa physiologica (Oxford, England)2024

Role of calcineurin in regulating renal potassium (K

Xin-Peng Duan, Cheng-Biao Zhang, Wen-Hui Wang, Dao-Hong Lin

Abstract readReview
In one paragraph

Review in Acta physiologica (Oxford, England), 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed.

  1. Review
  2. Review
  3. Review
  4. Article
  5. Article
  6. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Xin-Peng DuanDepartment of Physiology, Xuzhou Medical University, Xuzhou, China.
Cheng-Biao ZhangDepartment of Physiology, Xuzhou Medical University, Xuzhou, China.
Wen-Hui WangDepartment of Pharmacology, New York Medical College, Valhalla, New York, USA.ORCID 0000-0002-7503-9554
Dao-Hong LinDepartment of Pharmacology, New York Medical College, Valhalla, New York, USA.ORCID 0000-0003-1760-2684

Funding

Role of Kir4.1 in regulating NCC and ROMK in DCTR01DK133220 · NIDDK · NEW YORK MEDICAL COLLEGE · PI ELLISON, DAVID HOADLEY, WANG, WENHUI · 2022 to 2025
$2.6M
Regulation of Kir4.1/Kir5.1 and renal potassium excretionR01DK136491 · NIDDK · NEW YORK MEDICAL COLLEGE · PI Dao-Hong Lin · 2023 to 2026
$1.4M
NIDDK NIH HHS R01 DK133220NIDDK NIH HHS R01 DK136491NIH HHS
6 · The paper itself

Abstract

Calcineurin, protein phosphatase 2B (PP2B) or protein phosphatase 3 (PP3), is a calcium-dependent serine/threonine protein phosphatase. Calcineurin is widely expressed in the kidney and regulates renal Na

Indexed as

CalcineurinCalcineurin InhibitorsHyperkalemiaPotassiumAnimalsHumansKidneyCalcineurinCalcineurin InhibitorsPotassiumKir4.1/Kir5.1NCCNKCC2ROMK and aldosterone

Identifiers

PMID38860527
PMCPMC11250626

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.